Literature DB >> 24648693

Warfarin-induced skin necrosis.

Despoina D Kakagia1, Nikolaos Papanas2, Efthimios Karadimas3, Alexandros Polychronidis1.   

Abstract

Warfarin-induced skin necrosis is an infrequent complication occurring in individuals under warfarin treatment who have a thrombophilic history or after administration of large loading doses of warfarin particularly without simultaneous initial use of heparin. A 62-year-old lady developed skin necrosis 4 days after initiating warfarin therapy of 5 mg daily without initial co-administration of heparin. The patient had a normal clotting profile. Skin necrosis progressed to eschar formation after cessation of warfarin and heparinization stopped expanding. Warfarin was reintroduced at 2 mg daily, initially together with low molecular weight heparin. Autolytic debridement of the necrotic tissue was followed by healing of the cutaneous deficit by secondary intention. Prompt diagnosis and discontinuation of warfarin are crucial for the prognosis.

Entities:  

Keywords:  Anticoagulants; Necrotic lesions; Warfarin

Year:  2014        PMID: 24648693      PMCID: PMC3956802          DOI: 10.5021/ad.2014.26.1.96

Source DB:  PubMed          Journal:  Ann Dermatol        ISSN: 1013-9087            Impact factor:   1.444


  7 in total

1.  Acquired functional protein S deficiency, cerebral venous thrombosis, and coumarin skin necrosis in association with antiphospholipid syndrome: report of two cases.

Authors:  J Moreb; C S Kitchens
Journal:  Am J Med       Date:  1989-08       Impact factor: 4.965

Review 2.  Warfarin-induced skin necrosis.

Authors:  C S Eby
Journal:  Hematol Oncol Clin North Am       Date:  1993-12       Impact factor: 3.722

3.  Coumarin-induced skin necrosis associated with acquired protein S deficiency and antiphospholipid antibody syndrome.

Authors:  M J Wattiaux; R Hervé; A Robert; J Cabane; B Housset; J C Imbert
Journal:  Arthritis Rheum       Date:  1994-07

4.  Protein C and the development of skin necrosis during anticoagulant therapy.

Authors:  A W Broekmans; R M Bertina; E A Loeliger; V Hofmann; H G Klingemann
Journal:  Thromb Haemost       Date:  1983-06-28       Impact factor: 5.249

5.  Venous limb gangrene during warfarin treatment of cancer-associated deep venous thrombosis.

Authors:  T E Warkentin
Journal:  Ann Intern Med       Date:  2001-10-16       Impact factor: 25.391

Review 6.  Warfarin-induced skin necrosis.

Authors:  Rosalynn M Nazarian; Elizabeth M Van Cott; Artur Zembowicz; Lyn M Duncan
Journal:  J Am Acad Dermatol       Date:  2009-08       Impact factor: 11.527

Review 7.  Protein S and C4b-binding protein: components involved in the regulation of the protein C anticoagulant system.

Authors:  B Dahlbäck
Journal:  Thromb Haemost       Date:  1991-07-12       Impact factor: 5.249

  7 in total
  12 in total

Review 1.  2018 Expert Consensus on the Management of Adverse Effects of Antiplatelet Therapy for Acute Coronary Syndrome in Taiwan.

Authors:  Yi-Heng Li; Chih-Yuan Fang; I-Chang Hsieh; Wei-Chun Huang; Tsung-Hsien Lin; Shih-Hsien Sung; Chiung-Zuan Chiu; Chiung-Jen Wu; Kou-Gi Shyu; Po-Yuan Chang; Ching-Chang Fang; Tse-Min Lu; Ching-Pei Chen; Wei-Chen Tai; Chau-Chyun Sheu; Kai-Che Wei; Yi-Hsiu Huang; Hsing-Mei Wu; Juey-Jen Hwang Hwang
Journal:  Acta Cardiol Sin       Date:  2018-05       Impact factor: 2.672

2.  Warfarin-Induced Skin Necrosis in the Presence of Acute Hepatic Injury and May-Thurner Syndrome.

Authors:  Carrie Tilton; Spencer Livengood; Jeremy Hodges; Jessica Marshall
Journal:  Hosp Pharm       Date:  2018-05-18

3.  Concurrent Hand and Penile Gangrene following Prolonged Warfarin Use; a Case Report.

Authors:  Fatemeh Mahdizadeh; Saeed Safari
Journal:  Emerg (Tehran)       Date:  2017-06-21

Review 4.  Pigmented purpura and cutaneous vascular occlusion syndromes.

Authors:  Ana Cecilia Lamadrid-Zertuche; Verónica Garza-Rodríguez; Jorge de Jesús Ocampo-Candiani
Journal:  An Bras Dermatol       Date:  2018-06       Impact factor: 1.896

5.  Successful treatment of warfarin-induced skin necrosis using oral rivaroxaban: A case report.

Authors:  Momoka Kamada; Tsuneaki Kenzaka
Journal:  World J Clin Cases       Date:  2019-12-26       Impact factor: 1.337

Review 6.  A 78-Year-Old Man with a Pulmonary Embolism Who Developed Skin Necrosis 7 Days After Treatment with the Direct Oral Anticoagulant Factor Xa Inhibitor Apixaban.

Authors:  Tusharkumar Pansuriya; Trung Nguyen; Mir Ali Sadat; Syed A Raza; Siva T Sarva
Journal:  Am J Case Rep       Date:  2021-01-25

7.  Warfarin-induced skin necrosis: a rare condition.

Authors:  Josephine Nsaful; Yaw Ofori Adjei; Florence Dedey; Nelson Agboadoh; Edem Anyigba; Warigbani Pieterson
Journal:  Ghana Med J       Date:  2020-12

8.  Eruption of hemorrhagic bullae and vesicles.

Authors:  Sabah Osmani; Jiasen Wang; Hillary Elwood; Therese A Holguin
Journal:  JAAD Case Rep       Date:  2022-01-14

9.  Warfarin skin necrosis mimicking calciphylaxis in a patient with secondary hyperparathyroidism undergoing peritoneal dialysis.

Authors:  Jee Eun Park; Seonggyu Byeon; Hee Kyung Kim; Seong Mi Moon; Ji Hoon Moon; Kee-Taek Jang; Byung-Jae Lee; Hye Ryoun Jang; Wooseong Huh; Dae Joong Kim; Yoon-Goo Kim; Ha Young Oh; Jung Eun Lee
Journal:  Kidney Res Clin Pract       Date:  2015-08-12

10.  Structural and Binding Effects of Chemical Modifications on Thrombin Binding Aptamer (TBA).

Authors:  Vibhav Valsangkar; Sweta Vangaveti; Goh Woon Lee; Walid M Fahssi; Waqas S Awan; Yicheng Huang; Alan A Chen; Jia Sheng
Journal:  Molecules       Date:  2021-07-30       Impact factor: 4.927

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.